Nov 28, 2017:
iCo Therapeutics Announces Third Quarter 2017 Financial Results

Nov 22, 2017:
iCo Therapeutics Announces Ethics Approval for its Oral Amphotericin B Phase 1 Clinical Study

Sep 7, 2017:
iCo Therapeutics Announces Upcoming Presentations and Meetings

Aug 29, 2017:
iCo Therapeutics Announces Second Quarter 2017 Financial Results

Aug 4, 2017:
iCo Therapeutics Inc. Approves Advance Notice Policy

Jun 30, 2017:
iCo Therapeutics Announces Election of Directors

Jun 15, 2017:
iCo Therapeutics Announces Pre IND meeting for Novel Glaucoma Asset

Jun 12, 2017:
iCo Therapeutics Announces Positive Oral Amphotericin Study

May 24, 2017:
iCo Therapeutics Announces First Quarter 2017 Financial Results

Apr 19, 2017:
iCo Therapeutics Announces Year End 2016 Financial Results

Mar 13, 2017:
iCo Therapeutics Inc. Announces No Material Change